← Leaderboards
Gordana D. Vitaliano
Mclean Hospital
$5,822,112
Attributed
$10,649,495
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,649,495 · 8
By mechanism
R44$8,990,250 · 4
K08$757,728 · 1
R43$664,517 · 2
R03$237,000 · 1
Top collaborators
- Franco Vitaliano15 shared
Most similar at Mclean Hospital
Same institution · by research overlap
- Dost Ongur$17,996,987
- Matthew D Sacchet$1,250,000
- Sabina Berretta$31,866,827
- Torsten Klengel$1,205,901
- Guia Guffanti$319,623
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposClathrinRecoveryChronicNanotechnologyMonitorDiagnosisMolecularSeriesBrainEffectivenessPharmaceutical PreparationsBrain RegionMagnetic Resonance ImagingAnimal ModelBlood - Brain Barrier AnatomyBypassDrug Delivery SystemsNanoparticleCellsIn VivoProteinsFoundationsDisease Progression
Grant awards (20)
New Nanoprobes for MR Imaging of TrkB in Alzheimer's Disease$499,588
R44 · FY2025 · AG
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease$995,987
R44 · FY2024 · AG
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease$995,987
R44 · FY2023 · AG
New targeted BDNF nanoparticles for treatment of METH addiction and neurotoxicity$1,184,259
R44 · FY2022 · DA
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease$1,006,687
R44 · FY2022 · AG
New targeted BDNF nanoparticles for treatment of METH addiction and neurotoxicity$1,194,659
R44 · FY2021 · DA
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease$100,002
R44 · FY2020 · AG
Preventing and Reducing HAND by Using New BDNF Nanoprobes$749,720
R44 · FY2019 · MH
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease$749,493
R44 · FY2019 · AG
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease$749,693
R44 · FY2018 · AG
Preventing and Reducing HAND by Using New BDNF Nanoprobes$539,377
R44 · FY2018 · MH
Nanoengineered Neuroprobes for MRI of Dopamine Transporters in Drug Addiction$196,560
K08 · FY2018 · DA · contact PI
New Targeted BDNF Nanoparticles for Treatment of Dopaminergic Neurodegeneration in METH Addiction and HAND$225,000
R43 · FY2017 · DA
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease$224,798
R44 · FY2017 · AG
Nanoengineered Neuroprobes for MRI of Dopamine Transporters in Drug Addiction$196,560
K08 · FY2017 · DA · contact PI
Preventing and Reducing HAND by Using New BDNF Nanoprobes$214,457
R43 · FY2016 · MH
Nanoengineered Neuroprobes for MRI of Dopamine Transporters in Drug Addiction$182,304
K08 · FY2016 · DA · contact PI
Preventing and Reducing HAND by Using New BDNF Nanoprobes$225,060
R43 · FY2015 · MH
Nanoengineered Neuroprobes for MRI of Dopamine Transporters in Drug Addiction$182,304
K08 · FY2015 · DA · contact PI
New Dopamine Transporter MRI Nanoprobes for Addiction Research$237,000
R03 · FY2009 · DA · contact PI